Regulatory role of cyclic adenosine 3′,5′-monophosphate on the plattelet cyclooxygenase and platelet function
- 4 January 1979
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 582 (1), 44-58
- https://doi.org/10.1016/0304-4165(79)90287-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets.Proceedings of the National Academy of Sciences, 1977
- : A selective inhibitor of thromboxane synthetaseProstaglandins, 1977
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977
- Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.Journal of Clinical Investigation, 1977
- The chemical structure of prostaglandin X (prostacyclin)Prostaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Thromboxanes: Selective Biosynthesis and Distinct Biological PropertiesScience, 1976
- Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human plateletsBiochemical and Biophysical Research Communications, 1976
- Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acidInflammation Research, 1975